{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:21:51Z","timestamp":1793467311267,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00277-025-06433-8","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T01:44:03Z","timestamp":1754531043000},"page":"4831-4836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["\u201cIn situ\u201d MYC rearrangement and amplification as a secondary change in a case of High-grade B cell lymphoma with 11q aberration"],"prefix":"10.1007","volume":"104","author":[{"given":"Gioia","family":"Di Stefano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Bens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ciceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Nassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Santi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"issue":"7","key":"6433_CR1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36(7):1720\u20131748. https:\/\/doi.org\/10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"issue":"11","key":"6433_CR2","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR et al (2022) The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood 140(11):1229\u20131253. https:\/\/doi.org\/10.1182\/blood.2022015851","journal-title":"Blood"},{"issue":"27","key":"6433_CR3","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1200\/JCO.24.00070","volume":"42","author":"E Campo","year":"2024","unstructured":"Campo E, Dierickx D, Dirnhofer S et al (2024) Lymphoma classifications, how to develop a future unified taxonomy. J Clin Oncol 42(27):3177\u20133182. https:\/\/doi.org\/10.1200\/JCO.24.00070","journal-title":"J Clin Oncol"},{"issue":"8","key":"6433_CR4","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","volume":"123","author":"I Salaverria","year":"2014","unstructured":"Salaverria I, Martin-Guerrero I, Wagener R et al (2014) A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Blood 123(8):1187\u20131198. https:\/\/doi.org\/10.1182\/blood-2013-06-507996","journal-title":"Blood"},{"issue":"9","key":"6433_CR5","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1182\/blood-2018-07-864025","volume":"133","author":"R Wagener","year":"2019","unstructured":"Wagener R, Seufert J, Raimondi F et al (2019) The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma. Blood 133(9):962\u2013966. https:\/\/doi.org\/10.1182\/blood-2018-07-864025","journal-title":"Blood"},{"issue":"20","key":"6433_CR6","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the world health organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"issue":"6","key":"6433_CR7","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/bjh.13501","volume":"170","author":"SM Aukema","year":"2015","unstructured":"Aukema SM, Theil L, Rohde M et al (2015) Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations. Br J Haematol 170(6):814\u2013825. https:\/\/doi.org\/10.1111\/bjh.13501","journal-title":"Br J Haematol"},{"issue":"3","key":"6433_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/ajcp\/aqx139","volume":"209","author":"V Havelange","year":"2016","unstructured":"Havelange V, Ameye G, Th\u00e9ate I et al (2016) The peculiar 11q-gain\/loss aberration reported in a subset of MYC-negative high-grade B-cell lymphomas can also occur in a MYC-rearranged lymphoma. Cancer Genet 209(3):117\u2013118. https:\/\/doi.org\/10.1093\/ajcp\/aqx139","journal-title":"Cancer Genet"},{"issue":"1","key":"6433_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/ajcp\/aqx139","volume":"149","author":"B Grygalewicz","year":"2017","unstructured":"Grygalewicz B, Woroniecka R, Rymkiewicz G et al (2017) The 11q-Gain\/Loss aberration occurs recurrently in MYC-Negative Burkitt-like lymphoma with 11q aberration, as well as MYC-Positive Burkitt lymphoma and MYC-Positive High-Grade B-Cell lymphoma, NOS. Am J Clin Pathol 149(1):17\u201328. https:\/\/doi.org\/10.1093\/ajcp\/aqx139","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"6433_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00428-023-03590-x","volume":"483","author":"L Quintanilla-Martinez","year":"2023","unstructured":"Quintanilla-Martinez L, Laurent C, Soma L et al (2023) Emerging entities: high-grade\/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP\/SH lymphoma workshop. Virchows Arch 483(3):281\u2013298. https:\/\/doi.org\/10.1007\/s00428-023-03590-x","journal-title":"Virchows Arch"},{"issue":"3","key":"6433_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/ijc.10169","volume":"98","author":"JI Mart\u00edn-Subero","year":"2002","unstructured":"Mart\u00edn-Subero JI, Harder L, Gesk S et al (2002) Interphase FISH assays for the detection of translocations with breakpoints in Immunoglobulin light chain loci. Int J Cancer 98(3):470\u2013474. https:\/\/doi.org\/10.1002\/ijc.10169","journal-title":"Int J Cancer"},{"issue":"23","key":"6433_CR12","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa055351","volume":"354","author":"M Hummel","year":"2006","unstructured":"Hummel M, Bentink S, Berger H et al (2006) Molecular mechanisms in malignant lymphomas network project of the Deutsche Krebshilfe. A biologic definition of Burkitt\u2019s lymphoma from transcriptional and genomic profiling. N Engl J Med 354(23):2419\u20132430. https:\/\/doi.org\/10.1056\/NEJMoa055351","journal-title":"N Engl J Med"},{"issue":"9","key":"6433_CR13","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.3324\/haematol.2018.207928","volume":"104","author":"B Gonzalez-Farre","year":"2019","unstructured":"Gonzalez-Farre B, Ramis-Zaldivar JE, Salmeron-Villalobos J et al (2019) Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma. Haematologica 104(9):1822\u20131829. https:\/\/doi.org\/10.3324\/haematol.2018.207928","journal-title":"Haematologica"},{"issue":"1","key":"6433_CR14","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41467-019-08578-3","volume":"10","author":"C L\u00f3pez","year":"2019","unstructured":"L\u00f3pez C, Kleinheinz K, Aukema SM et al (2019) Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma. Nat Commun 10(1):1459. https:\/\/doi.org\/10.1038\/s41467-019-08578-3","journal-title":"Nat Commun"},{"issue":"7","key":"6433_CR15","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1038\/s41375-021-01251-z","volume":"35","author":"D H\u00fcbschmann","year":"2021","unstructured":"H\u00fcbschmann D, Kleinheinz K, Wagener R et al (2021) Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas. Leukemia 35(7):2002\u20132016. https:\/\/doi.org\/10.1038\/s41375-021-01251-z","journal-title":"Leukemia"},{"issue":"4","key":"6433_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/gcc.20187","volume":"43","author":"JI Mart\u00edn-Subero","year":"2005","unstructured":"Mart\u00edn-Subero JI, Odero MD, Hernandez R et al (2005) Amplification of IGH\/MYC fusion in clinically aggressive IGH\/BCL2-positive germinal center B-cell lymphomas. Genes Chromosomes Cancer 43(4):414\u2013423. https:\/\/doi.org\/10.1002\/gcc.20187","journal-title":"Genes Chromosomes Cancer"},{"issue":"15","key":"6433_CR17","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1182\/blood.2024025603","volume":"144","author":"B Collinge","year":"2024","unstructured":"Collinge B, Ben-Neriah S, Hilton LK et al (2024) Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2. Blood 144(15):1611\u20131616. https:\/\/doi.org\/10.1182\/blood.2024025603","journal-title":"Blood"},{"issue":"4","key":"6433_CR18","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s12032-010-9614-0","volume":"28","author":"B Pienkowska-Grela","year":"2011","unstructured":"Pienkowska-Grela B, Rymkiewicz G, Grygalewicz B et al (2011) Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement. Med Oncol 28(4):1589\u20131595. https:\/\/doi.org\/10.1007\/s12032-010-9614-0","journal-title":"Med Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06433-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06433-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06433-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:30:26Z","timestamp":1761283826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06433-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["6433"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06433-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patient for the publication of this report and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}